Stock Code: 000553 (200553) Stock abbreviation: ADAMA A (B) Announcement No. 2023-2
ADAMA Ltd.
2022 Full Year Performance Estimation
The Company and all the directors confirm that the information disclosed herein is true,
accurate, complete and contains no false recording, misleadingstatement or material omission.
I. Performance Estimation
1. Estimation period: January to December 2022
2. Estimated net profit: increase compared with the corresponding period last year
Item Current reporting period Same period last year
January to December January to December
2022 2021
Net income attributable to the 418-625
shareholders of the listed company 157
(RMB in millions) Percentage increase YoY
166.2% - 298.1%
Net income excluding non-recurring 305 - 512
profits and losses 78
(RMB in millions) Percentage increase YoY
291.0% - 556.4%
Basic earnings per share 0.1792 - 0.2685 0.0676
(RMB)
Note: The ‘non-recurring profits and losses’ referred to above are as defined in the Explanatory Announcement No. 1
on Information Disclosure for Companies Offering their Securities to the Public-Non-Recurring Profit and Loss.
II. Pre-audit of the estimatedperformance
The estimated results of this period are the preliminary estimation of the Company and have not
been audited nor reviewed by certified accountants.
III. Explanations for Performance Variation
Sales
For the full year of 2022, ADAMA is expecting to report a growth in sales of approximately 20%
in RMB terms (16% in USD terms), compared to the same period last year.
Theexpected strong growth over the full year was primarily driven by a significant, more than 10%
increase in prices, a trend which started in the third quarter of 2021, complemented by volume
growth and achieved despite the negative impact of exchange rates and supply challenges. This
growth is a reflection of the robust demand in the market resulting from the elevated global crop
prices during 2022. The Company's performance was particularly strong in Brazil, where the
Company continues to work to strengthen its position within this growing market, while the
Company's sales in China continued to grow strongly, also due to consolidation during 2021 of a
newly acquired subsidiary.
EBITDA
In the full year of 2022, the Company is expecting to report an increase in EBITDA and in its
margin in comparison to 2021. The strong top-line growth more than compensated for the impacts
of higher procurement, production and logistics costs, exchange rates as well as higher operating
costs, which were impacted amongst other factors by higher inflation.
It should be noted that certain relocation and upgrade charges have significantly declined since
Q1 2022, as the relocation and upgrade of the manufacturing Jingzhou site in China has been
completed and is now at a high level of operation.
Net Income
In the full year of 2022, the Company is expecting to report an increase in Net Income compared
to 2021, following achieving higher Operating Profit and despite a significant increase in financial
expenses in light of the high Israeli CPI, higher hedging costs on exchange rates and an increase
in interest rates.
In the fourth quarter of 2022, the Company is expected to record a non-recurring, non-cash
provision for asset impairment in its subsidiaries (please refer to Announcement on Assets
Impairment (Announcement No. 2023-3) for details) and income due to revaluation of put options
attributed to minority stakes in one of these subsidiaries.
The Company’s reported Net Income in 2022 is expected to reflect net expenses in respect of
certain transitory, non-operational or non-cash items, including mainly:
i. Non-cash amortization charges in respect of Transfer assets received from Syngenta
related to the 2017 ChemChina-Syngenta acquisition;
ii. Non-cash amortization net charges related to intangible assets created as part of the
Purchase Price Allocation (PPA) on acquisitions, with no impact on the ongoing
performance of the companies acquired;
iii. Manufacturing facilities relocation & upgrade-related costs: certain extraordinary charges
related largely to a temporary disruption of the production of certain products, were
adjusted in 2021. These charges have significantly declined in 2022, as the relocation and
upgrade of the manufacturing Jingzhou site in China has been completed and is now at a
high level of operation;
iv. Incentive plans: ADAMA granted certai